BASF Acquires Lanxess Polyisobutene Knowhow

BASF has agreed to acquire the polyisobutene business of compatriot chemical producer Lanxess for an undisclosed sum. The two companies said the deal concerns for the most part intellectual property for a new, innovative technology to produce high molecular weight polyisobutene (HM PIB).

Under the terms of the transaction, Lanxess will produce the new HM PIB for BASF in its existing facilities under a long term toll manufacturing agreement, and BASF will market the products under the "Oppanol" trademark.

The Ludwigshafen chemical giant said its other PIB offerings, including medium molecular weight PIB (MM PIB) and highly reactive PIB (HR PIB) will not be affected by the arrangement.

With more than 75 years of experience in producing polyisobutylene with different molecular weights, BASF claims to offer the broadest range worldwide.

Martin Widmann, senior vice president of BASF's global business unit Fuel and Lubricant Solutions, said acquiring the Lanxess technology will result in enhanced security of HM PIB supply as it provides the basis for a long term oriented sustainable growth with high quality products for a broad range of applications.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.